Navigation Links
Glaucoma may be delayed by eye drops

Glaucoma is one of the leading causes of blindness. The cause of eye damage in some otherwise healthy eyes is a raised pressure within the eye, (the intraocular pressure), that can damage the nerve over a period of time and this damage results in poor blood supply or weak end eye structure.// Its caused when raised pressure inside the eyeball damages the optic nerve leading to the brain. Fluid enters and leaves the eyeball all the time - it's when it drains away too slowly that pressure increases.

A team of researchers at University of Texas found that this is the first to assess the long-term effect of eye drops that lower the eyeball (intraocular) pressure on those at risk of glaucoma. They examined 1,502 people aged between 45 and 82 who had increased intraocular pressure - placing around half on a regime of daily eye drop treatment. The drops contain a medication known to lower the pressure. The rest were closely monitored by eye specialists, but did not receive eye drops.

At the end of the five year study, only 4.5 per cent in the eye drop group had developed glaucoma, compared to 8.2 per cent of the controls. Researchers felt that it is an impressive finding, given that the eye drops lower intraocular pressure by just 25 per cent.


'"/>




Page: 1

Related medicine news :

1. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
2. Progression of Glaucoma could be controlled with early detection
3. Early Screening Required for Glaucoma
4. Adding An Additional Drug May Help Patients With Glaucoma
5. Heavy Computer Use May Result In Glaucoma
6. A Drop a day Can Keep Glaucoma At Bay
7. Millions Of Diabetic And Glaucoma Patients Risk Blindness
8. Glaucoma Could Cause Vision Loss In 60 Million People By 2010
9. Glaucoma Camp Held
10. Type 2 Diabetes Increases the Risk of Glaucoma in Women
11. Weightlifting Could Enhance Glaucoma Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... 07, 2016 , ... They are musicians and librarians, fashion designers and fitness ... from New England and around the nation. What do they have in common? All ... a beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan International ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... and financial consultation services to residents in the Sacramento/Folsom region, is initiating a ... treatment facility. , The Another Choice Another Chance treatment center in Sacramento works ...
(Date:12/7/2016)... ... ... A. Kevin Spann Insurance, a New York-based firm offering insurance and financial consultation ... drive to raise funds that will benefit the Marine Corps League. , The Marine ... Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans to generate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
(Date:12/6/2016)... 2016  Nearly 30 million people in ... of diabetes. 1 However, nearly 40% of diabetes ... (hyperglycemia) and significant glucose variability. 2 These patients are ... events. If left untreated, hyperglycemia can lead to cardiovascular ... blindness. 3 As part of Diabetes ...
(Date:12/6/2016)... 2016  Arcturus Therapeutics, Inc. ("Arcturus" or the ... that it entered into collaboration with Takeda Pharmaceutical ... treatment of NASH and other gastrointestinal (GI) related ... and UNA Oligomer chemistry. The financial terms were ... to and expertise in GI disorders, we are ...
Breaking Medicine Technology: